{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:48:51Z","timestamp":1777999731420,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.818193\/2023-00"],"award-info":[{"award-number":["88887.818193\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305373\/2023-4"],"award-info":[{"award-number":["305373\/2023-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04567-9","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T04:41:21Z","timestamp":1752295281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Amber LED photobiomodulation versus tranexamic acid for the treatment of melasma: randomized controlled double-blind pilot trial"],"prefix":"10.1007","volume":"40","author":[{"given":"Thais Rodrigues","family":"Galache","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Galache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Taylor de Brito","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cicero Dayves da Silva","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Mota","family":"Sena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Pavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"4567_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/exd.13844","volume":"28","author":"S Kwon","year":"2019","unstructured":"Kwon S, Na J, Choi J, Park K (2019) Melasma: updates and perspectives. Exp Dermatol 28:704\u2013708. https:\/\/doi.org\/10.1111\/exd.13844","journal-title":"Exp Dermatol"},{"key":"4567_CR2","doi-asserted-by":"publisher","unstructured":"Galache TR, Sena MM, Tassinary JAF, Pavani C (2024) Photobiomodulation for melasma treatment: integrative review and state of the art. Photodermatology. Photoimmunology Photomed 40. https:\/\/doi.org\/10.1111\/phpp.12935","DOI":"10.1111\/phpp.12935"},{"key":"4567_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an Up-to-Date comprehensive review. Dermatol Ther (Heidelb) 7:305\u2013318. https:\/\/doi.org\/10.1007\/s13555-017-0194-1","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4567_CR4","doi-asserted-by":"publisher","unstructured":"Dias MO, Minagawa FH, Teixeira de Abreu AF et al (2024) Prevalence of facial melasma among adult women in a multiracial population. Int J Dermatol 63. https:\/\/doi.org\/10.1111\/ijd.17078","DOI":"10.1111\/ijd.17078"},{"key":"4567_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/ijd.17522","volume":"64","author":"J Ocampo-Candiani","year":"2025","unstructured":"Ocampo-Candiani J, Alas\u2010Carbajal R, Bonifaz\u2010Araujo JF et al (2025) Latin American consensus on the treatment of melasma. Int J Dermatology 64:499\u2013512. https:\/\/doi.org\/10.1111\/ijd.17522","journal-title":"Int J Dermatology"},{"key":"4567_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/jocd.12911","volume":"18","author":"R Sarkar","year":"2019","unstructured":"Sarkar R, Ghunawat S, Narang I et al (2019) Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and melasma quality of life index in melasma. J Cosmet Dermatol 18:1066\u20131073. https:\/\/doi.org\/10.1111\/jocd.12911","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.abd.2021.05.012","volume":"97","author":"FAS Addor","year":"2022","unstructured":"Addor FAS, Barcaui CB, Gomes EE et al (2022) Sunscreen lotions in the dermatological prescription: review of concepts and controversies. An Bras Dermatol 97:204\u2013222. https:\/\/doi.org\/10.1016\/j.abd.2021.05.012","journal-title":"An Bras Dermatol"},{"key":"4567_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMicm2305739","volume":"390","author":"N Patel","year":"2024","unstructured":"Patel N, Shah H (2024) Exogenous ochronosis from Skin-Lightening cream. N Engl J Med 390:254\u2013254. https:\/\/doi.org\/10.1056\/NEJMicm2305739","journal-title":"N Engl J Med"},{"key":"4567_CR9","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cells11243949","volume":"11","author":"X Dai","year":"2022","unstructured":"Dai X, Jin S, Xuan Y et al (2022) 590 Nm LED irradiation improved erythema through inhibiting angiogenesis of human microvascular endothelial cells and ameliorated pigmentation in melasma. Cells 11:3949. https:\/\/doi.org\/10.3390\/cells11243949","journal-title":"Cells"},{"key":"4567_CR10","doi-asserted-by":"publisher","unstructured":"Xuan YJ, Dai XX, Chen L et al (2024) Efficacy and safety of home-based 590 Nm light-emitting diodes and in-hospital 1064 Nm Q-switched nd:yag laser in the treatment of facial melasma: A single-centre, prospective, randomized clinical trial. J Eur Acad Dermatol Venereol 38. https:\/\/doi.org\/10.1111\/jdv.19510","DOI":"10.1111\/jdv.19510"},{"key":"4567_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/phpp.12276","volume":"33","author":"CT Oh","year":"2017","unstructured":"Oh CT, Kwon T, Choi EJ et al (2017) Inhibitory effect of 660-nm LED on melanin synthesis in in vitro and in vivo. PhotoDermatol PhotoImmunol PhotoMed 33:49\u201357. https:\/\/doi.org\/10.1111\/phpp.12276","journal-title":"PhotoDermatol PhotoImmunol PhotoMed"},{"key":"4567_CR12","doi-asserted-by":"publisher","unstructured":"Frankowski DW, Ferrucci L, Arany PR et al (2025) Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy. https:\/\/doi.org\/10.1007\/s11357-025-01505-z. GeroScience","DOI":"10.1007\/s11357-025-01505-z"},{"key":"4567_CR13","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3390\/ijms25084483","volume":"25","author":"ML Hern\u00e1ndez-Bule","year":"2024","unstructured":"Hern\u00e1ndez-Bule ML, Naharro-Rodr\u00edguez J, Bacci S, Fern\u00e1ndez-Guarino M (2024) Unlocking the power of light on the skin: A comprehensive review on photobiomodulation. Int J Mol Sci 25:4483. https:\/\/doi.org\/10.3390\/ijms25084483","journal-title":"Int J Mol Sci"},{"key":"4567_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdermsci.2017.10.001","volume":"89","author":"L Chen","year":"2018","unstructured":"Chen L, Xu Z, Jiang M et al (2018) Light-emitting diode 585 Nm photomodulation inhibiting melanin synthesis and inducing autophagy in human melanocytes. J Dermatol Sci 89:11\u201318. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.10.001","journal-title":"J Dermatol Sci"},{"key":"4567_CR15","doi-asserted-by":"publisher","unstructured":"Calacattawi R, Alshahrani M, Aleid M et al (2024) Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials. J Dermatological Treat 35. https:\/\/doi.org\/10.1080\/09546634.2024.2361106","DOI":"10.1080\/09546634.2024.2361106"},{"key":"4567_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jocd.15589","volume":"22","author":"H Konisky","year":"2023","unstructured":"Konisky H, Balazic E, Jaller JA et al (2023) Tranexamic acid in melasma: A focused review on drug administration routes. J Cosmet Dermatology 22:1197\u20131206. https:\/\/doi.org\/10.1111\/jocd.15589","journal-title":"J Cosmet Dermatology"},{"key":"4567_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/ijd.16160","volume":"62","author":"KM Kim","year":"2023","unstructured":"Kim KM, Lim HW (2023) The uses of Tranexamic acid in dermatology: a review. Int J Dermatology 62:589\u2013598. https:\/\/doi.org\/10.1111\/ijd.16160","journal-title":"Int J Dermatology"},{"key":"4567_CR18","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2023.62.02.16","author":"K Ga\u0107ina","year":"2023","unstructured":"Ga\u0107ina K (2023) The use of Tranexamic acid in dermatology. Acta Clin Croatica. https:\/\/doi.org\/10.20471\/acc.2023.62.02.16","journal-title":"Acta Clin Croatica"},{"key":"4567_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5021\/ad.23.108","volume":"36","author":"L-X Liu","year":"2024","unstructured":"Liu L-X, Liao Z-K, Dong B-Q et al (2024) Tranexamic acid ameliorates skin hyperpigmentation by downregulating Endothelin-1 expression in dermal microvascular endothelial cells. Ann Dermatol 36:151. https:\/\/doi.org\/10.5021\/ad.23.108","journal-title":"Ann Dermatol"},{"key":"4567_CR20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.7150\/ijms.44188","volume":"17","author":"J-W Zhu","year":"2020","unstructured":"Zhu J-W, Ni Y-J, Tong X-Y et al (2020) Tranexamic acid inhibits angiogenesis and melanogenesis in vitro by targeting VEGF receptors. Int J Med Sci 17:903\u2013911. https:\/\/doi.org\/10.7150\/ijms.44188","journal-title":"Int J Med Sci"},{"key":"4567_CR21","doi-asserted-by":"publisher","unstructured":"Lee KW, Kim M, Lee SH, Kim KD (2022) The function of autophagy as a regulator of melanin homeostasis. https:\/\/doi.org\/10.3390\/cells11132085. Cells 11:2085","DOI":"10.3390\/cells11132085"},{"key":"4567_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jdermsci.2017.05.019","volume":"88","author":"YH Cho","year":"2017","unstructured":"Cho YH, Park JE, Lim DS, Lee JS (2017) Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells. J Dermatol Sci 88:96\u2013102. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.05.019","journal-title":"J Dermatol Sci"},{"key":"4567_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1683414","volume":"2018","author":"L Zhang","year":"2018","unstructured":"Zhang L, Tan W-Q, Fang Q-Q et al (2018) Tranexamic acid for adults with melasma: A systematic review and Meta-Analysis. Biomed Res Int 2018:1\u201313. https:\/\/doi.org\/10.1155\/2018\/1683414","journal-title":"Biomed Res Int"},{"key":"4567_CR24","doi-asserted-by":"publisher","first-page":"e073568","DOI":"10.1136\/bmjopen-2023-073568","volume":"13","author":"TR Galache","year":"2023","unstructured":"Galache TR, Galache M, Sena MM, Pavani C (2023) Amber photobiomodulation versus Tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial. BMJ Open 13:e073568. https:\/\/doi.org\/10.1136\/bmjopen-2023-073568","journal-title":"BMJ Open"},{"key":"4567_CR25","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332\u2013c332. https:\/\/doi.org\/10.1136\/bmj.c332","journal-title":"BMJ"},{"key":"4567_CR26","unstructured":"IBGE - Instituto Brasileiro de Geografia e Estat\u00edstica CENSO (2022) https:\/\/censo2022.ibge.gov.br\/panorama\/?utm_source=ibge&utm_medium=home&utm_campaign=portal"},{"key":"4567_CR27","doi-asserted-by":"publisher","unstructured":"Jagdeo J, Nguyen JK, Ho D et al (2020) Safety of light emitting diode-red light on human skin: two randomized controlled trials. J Biophotonics 13. https:\/\/doi.org\/10.1002\/jbio.201960014","DOI":"10.1002\/jbio.201960014"},{"key":"4567_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jaad.2023.10.074","volume":"91","author":"J Mineroff","year":"2024","unstructured":"Mineroff J, Maghfour J, Ozog DM et al (2024) Photobiomodulation CME part II: clinical applications in dermatology. J Am Acad Dermatol 91:805\u2013815. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.074","journal-title":"J Am Acad Dermatol"},{"key":"4567_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jaad.2023.10.073","volume":"91","author":"J Maghfour","year":"2024","unstructured":"Maghfour J, Ozog DM, Mineroff J et al (2024) Photobiomodulation CME part I: overview and mechanism of action. J Am Acad Dermatol 91:793\u2013802. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.073","journal-title":"J Am Acad Dermatol"},{"key":"4567_CR30","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.euf.2023.10.003","volume":"9","author":"S Ofori","year":"2023","unstructured":"Ofori S, Tornberg SV, Kilpel\u00e4inen TP et al (2023) Pros and cons of noninferiority trials. Eur Urol Focus 9:711\u2013714. https:\/\/doi.org\/10.1016\/j.euf.2023.10.003","journal-title":"Eur Urol Focus"},{"key":"4567_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/pst.1716","volume":"15","author":"L Flight","year":"2016","unstructured":"Flight L, Julious SA (2016) Practical guide to sample size calculations: non-inferiority and equivalence trials. Pharm Stat 15:80\u201389. https:\/\/doi.org\/10.1002\/pst.1716","journal-title":"Pharm Stat"},{"key":"4567_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2133.2006.07590.x","volume":"156","author":"A Pandya","year":"2006","unstructured":"Pandya A, Berneburg M, Ortonne J-P, Picardo M (2006) Guidelines for clinical trials in melasma. Br J Dermatol 156:21\u201328. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07590.x","journal-title":"Br J Dermatol"},{"key":"4567_CR33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1369\/0022155410398001","volume":"59","author":"VS Carriel","year":"2011","unstructured":"Carriel VS, Aneiros-Fernandez J, Arias-Santiago S et al (2011) A novel histochemical method for a simultaneous staining of melanin and collagen fibers. J Histochem Cytochemistry 59:270\u2013277. https:\/\/doi.org\/10.1369\/0022155410398001","journal-title":"J Histochem Cytochemistry"},{"key":"4567_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","volume":"149","author":"R Balkrishnan","year":"2003","unstructured":"Balkrishnan R, Mcmichael AJ, Camacho FT et al (2003) Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 149:572\u2013577. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05419.x","journal-title":"Br J Dermatol"},{"key":"4567_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2133.2006.07591.x","volume":"156","author":"TF Cestari","year":"2006","unstructured":"Cestari TF, Hexsel D, Viegas ML et al (2006) Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 156:13\u201320. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07591.x","journal-title":"Br J Dermatol"},{"key":"4567_CR36","doi-asserted-by":"publisher","first-page":"111457","DOI":"10.1016\/j.jclinepi.2024.111457","volume":"173","author":"J Molero-Calafell","year":"2024","unstructured":"Molero-Calafell J, Bur\u00f3n A, Castells X, Porta M (2024) Intention to treat and per protocol analyses: differences and similarities. J Clin Epidemiol 173:111457. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111457","journal-title":"J Clin Epidemiol"},{"key":"4567_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/14764172.2012.685478","volume":"14","author":"P Kanechorn Na Ayuthaya","year":"2012","unstructured":"Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A (2012) Topical 5% Tranexamic acid for the treatment of melasma in asians: A double-blind randomized controlled clinical trial. J Cosmet Laser Therapy 14:150\u2013154. https:\/\/doi.org\/10.3109\/14764172.2012.685478","journal-title":"J Cosmet Laser Therapy"},{"key":"4567_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13555-017-0195-0","volume":"7","author":"N Atefi","year":"2017","unstructured":"Atefi N, Dalvand B, Ghassemi M et al (2017) Therapeutic effects of topical Tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatology Therapy 7:417\u2013424. https:\/\/doi.org\/10.1007\/s13555-017-0195-0","journal-title":"Dermatology Therapy"},{"key":"4567_CR39","first-page":"220","volume":"29","author":"A Erum","year":"2019","unstructured":"Erum A, Asad F, Kiran R et al (2019) Topical Tranexamic acid versus hydroquinone for patients presenting with melasma. J Pakistan Association Dermatologists 29:220\u2013224","journal-title":"J Pakistan Association Dermatologists"},{"key":"4567_CR40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/09546634.2020.1781755","volume":"33","author":"MM Gamea","year":"2022","unstructured":"Gamea MM, Kamal DA, Donia AA, Hegab DS (2022) Comparative study between topical Tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma. J Dermatological Treat 33:798\u2013804. https:\/\/doi.org\/10.1080\/09546634.2020.1781755","journal-title":"J Dermatological Treat"},{"key":"4567_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-5173(01)00980-2","volume":"235","author":"A Manosroi","year":"2002","unstructured":"Manosroi A, Podjanasoonthon K, Manosroi J (2002) Development of novel topical Tranexamic acid liposome formulations. Int J Pharm 235:61\u201370. https:\/\/doi.org\/10.1016\/S0378-5173(01)00980-2","journal-title":"Int J Pharm"},{"key":"4567_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jocd.12152","volume":"14","author":"M Banihashemi","year":"2015","unstructured":"Banihashemi M, Zabolinejad N, Jaafari MR et al (2015) Comparison of therapeutic effects of liposomal Tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol 14:174\u2013177. https:\/\/doi.org\/10.1111\/jocd.12152","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR43","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","volume":"27","author":"JI Na","year":"2013","unstructured":"Na JI, Choi SY, Yang SH et al (2013) Effect of Tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol 27:1035\u20131039. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04464.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4567_CR44","doi-asserted-by":"publisher","unstructured":"Badran AY, Ali AU, Gomaa AS (2021) Efficacy of topical versus intradermal injection of Tranexamic acid in Egyptian melasma patients: A randomised clinical trial. Australas J Dermatol 62. https:\/\/doi.org\/10.1111\/ajd.13575","DOI":"10.1111\/ajd.13575"},{"key":"4567_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.EWX.0000546169.90015.65","volume":"15","author":"AM Hassan","year":"2018","unstructured":"Hassan AM, Hassan GFR, Ismail MAF, El-Maghraby GM (2018) A comparative study between two topical treatments (tranexamic acid and flutamide) in the treatment of patients with melasma. J Egypt Women\u02bcs Dermatol Soc 15:144\u2013150. https:\/\/doi.org\/10.1097\/01.EWX.0000546169.90015.65","journal-title":"J Egypt Women\u02bcs Dermatol Soc"},{"key":"4567_CR46","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1111\/jocd.13301","volume":"19","author":"SP Ng","year":"2020","unstructured":"Ng SP, Marcant M, Davis AF (2020) In vitro human skin concentrations following topical application of 2% Tranexamic acid in co-enhancer cream and branded cream formulations. J Cosmet Dermatol 19:2656\u20132662. https:\/\/doi.org\/10.1111\/jocd.13301","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR47","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/jocd.13810","volume":"19","author":"X Xing","year":"2020","unstructured":"Xing X, Chen L, Xu Z et al (2020) The efficacy and safety of topical Tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma. J Cosmet Dermatol 19:3238\u20133244. https:\/\/doi.org\/10.1111\/jocd.13810","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR48","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1303a195","author":"S Mamdouh Kamal","year":"2023","unstructured":"Mamdouh Kamal S, Hegab DS, Mohamed El Maghraby G, Ahmad El- Ashmawy A (2023) Efficacy and safety of topical Tranexamic acid alone or in combination with either fractional carbon dioxide laser or microneedling for the treatment of melasma. Dermatology Practical. https:\/\/doi.org\/10.5826\/dpc.1303a195. & Conceptual e2023195","journal-title":"Dermatology Practical"},{"key":"4567_CR49","doi-asserted-by":"publisher","unstructured":"Winn D, Gilreath A, Pajuelo D et al (2025) Evaluation of the in vivo skin penetration of txvector by confocal Raman spectroscopy. J Cosmet Dermatol 24. https:\/\/doi.org\/10.1111\/jocd.16696","DOI":"10.1111\/jocd.16696"},{"key":"4567_CR50","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1111\/jocd.16409","volume":"23","author":"Z Cen","year":"2024","unstructured":"Cen Z, Chen Z, Wang D et al (2024) Evaluation of the safety and efficacy of skin penetration enhancer Putocrin\u00ae. J Cosmet Dermatol 23:3272\u20133280. https:\/\/doi.org\/10.1111\/jocd.16409","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR51","doi-asserted-by":"publisher","unstructured":"Tang J, Li Y, Hu X et al (2024) Enhancing Tranexamic acid penetration through AQP-3 protein triggering via ZIF\u20108 encapsulation for melasma and Rosacea therapy. Adv Healthc Mater 13. https:\/\/doi.org\/10.1002\/adhm.202304189","DOI":"10.1002\/adhm.202304189"},{"key":"4567_CR52","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.abd.2023.12.008","volume":"99","author":"AFT de Abreu","year":"2024","unstructured":"de Abreu AFT, Dias MO, Barbosa MMC et al (2024) Factors associated with facial melasma severity in Brazilian women: an internet-based survey\u22c6. An Bras Dermatol 99:918\u2013922. https:\/\/doi.org\/10.1016\/j.abd.2023.12.008","journal-title":"An Bras Dermatol"},{"key":"4567_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ics.12466","volume":"40","author":"C Serre","year":"2018","unstructured":"Serre C, Busuttil V, Botto J-M (2018) Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. Int J Cosmet Sci 40:328\u2013347. https:\/\/doi.org\/10.1111\/ics.12466","journal-title":"Int J Cosmet Sci"},{"key":"4567_CR54","doi-asserted-by":"publisher","first-page":"106749","DOI":"10.1016\/j.isci.2023.106749","volume":"26","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zeng H, Jiang L et al (2023) Heat promotes melanogenesis by increasing the paracrine effects in keratinocytes via the TRPV3\/Ca2+\/Hh signaling pathway. iScience 26:106749. https:\/\/doi.org\/10.1016\/j.isci.2023.106749","journal-title":"iScience"},{"key":"4567_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/BF02980030","volume":"26","author":"D-S Kim","year":"2003","unstructured":"Kim D-S, Park S-H, Kwon S-B et al (2003) Temperature regulates melanin synthesis in melanocytes. Arch Pharm Res 26:840. https:\/\/doi.org\/10.1007\/BF02980030","journal-title":"Arch Pharm Res"},{"key":"4567_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pain.2008.02.028","volume":"139","author":"MS Angst","year":"2008","unstructured":"Angst MS, Clark JD, Carvalho B et al (2008) Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: A Microdialysis study. Pain 139:15\u201327. https:\/\/doi.org\/10.1016\/j.pain.2008.02.028","journal-title":"Pain"},{"key":"4567_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00403-024-03755-x","volume":"317","author":"JM Lim","year":"2025","unstructured":"Lim JM, Sung HY, Park SW, Hwang JS (2025) IL-7 secreted by keratinocytes induces melanogenesis via c-kit\/MAPK signaling pathway in Melan-a melanocytes. Arch Dermatol Res 317:275. https:\/\/doi.org\/10.1007\/s00403-024-03755-x","journal-title":"Arch Dermatol Res"},{"key":"4567_CR58","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/ijd.14541","volume":"58","author":"R Sarkar","year":"2019","unstructured":"Sarkar R, Jagadeesan S, Basavapura Madegowda S et al (2019) Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India. Int J Dermatol 58:1305\u20131310. https:\/\/doi.org\/10.1111\/ijd.14541","journal-title":"Int J Dermatol"},{"key":"4567_CR59","doi-asserted-by":"crossref","unstructured":"World Meteorological Organization (WMO) (2024) State of the Global Climate 2023. https:\/\/wmo.int\/publication-series\/state-of-global-climate-2023. Accessed 12 Feb 2025","DOI":"10.18356\/9789263113474"},{"key":"4567_CR60","unstructured":"INSTITUTO NACIONAL DE METEOROLOGIA Inverno 2023 balan\u00e7o da esta\u00e7\u00e3o em S\u00e3o Paulo (SP)"},{"key":"4567_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s10103-024-04066-3","volume":"39","author":"H Yao","year":"2024","unstructured":"Yao H, Shen S, Gao X et al (2024) Definition of refractory melasma and its treatment: a review. Lasers Med Sci 39:118. https:\/\/doi.org\/10.1007\/s10103-024-04066-3","journal-title":"Lasers Med Sci"},{"key":"4567_CR62","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/ijd.IJD_488_17","volume":"62","author":"R Sarkar","year":"2017","unstructured":"Sarkar R, Aurangabadkar S, Salim T et al (2017) Lasers in melasma: A review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol 62:477. https:\/\/doi.org\/10.4103\/ijd.IJD_488_17","journal-title":"Indian J Dermatol"},{"key":"4567_CR63","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.13040\/IJPSR.0975-8232.10(5).2583-86","volume":"10","author":"S Saka","year":"2019","unstructured":"Saka S, Rao GRR, Komaram RB et al (2019) Efficacy of 10% topical Tranexamic acid in melasma - A randomized placebo-controlled split face study. Int J Pharm Sci Res 10:2583\u20132586. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.10(5).2583-86","journal-title":"Int J Pharm Sci Res"},{"key":"4567_CR64","first-page":"753","volume":"19","author":"B Ebrahimi","year":"2014","unstructured":"Ebrahimi B, Naeini FF (2014) Topical Tranexamic acid as a promising treatment for melasma. J Res Med Sci 19:753\u2013757","journal-title":"J Res Med Sci"},{"key":"4567_CR65","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/jocd.16104","volume":"23","author":"R Liang","year":"2024","unstructured":"Liang R, Luo H, Pan W et al (2024) Comparative efficacy and safety of Tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis. J Cosmet Dermatol 23:1150\u20131164. https:\/\/doi.org\/10.1111\/jocd.16104","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR66","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/jocd.15566","volume":"22","author":"Y Chang","year":"2023","unstructured":"Chang Y, Lee TL, Oyerinde O et al (2023) Efficacy and safety of topical agents in the treatment of melasma: what\u2019s evidence? A systematic review and meta-analysis. J Cosmet Dermatol 22:1168\u20131176. https:\/\/doi.org\/10.1111\/jocd.15566","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR67","doi-asserted-by":"publisher","first-page":"402001","DOI":"10.1088\/1361-6528\/ad5a15","volume":"35","author":"NR Castro","year":"2024","unstructured":"Castro NR, Pinto CDSC, Dos Santos EP, Mansur CRE (2024) Nanosystems with potential application as carriers for skin depigmenting actives. Nanotechnology 35:402001. https:\/\/doi.org\/10.1088\/1361-6528\/ad5a15","journal-title":"Nanotechnology"},{"key":"4567_CR68","first-page":"19","volume":"15","author":"V Gonz\u00e1lez-Molina","year":"2022","unstructured":"Gonz\u00e1lez-Molina V, Mart\u00ed-Pineda A, Gonz\u00e1lez N (2022) Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol 15:19\u201328","journal-title":"J Clin Aesthet Dermatol"},{"key":"4567_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jid.2019.11.003","volume":"140","author":"BCK Ly","year":"2020","unstructured":"Ly BCK, Dyer EB, Feig JL et al (2020) Research techniques made simple: cutaneous colorimetry: A reliable technique for objective skin color measurement. J Invest Dermatology 140:3\u201312e1. https:\/\/doi.org\/10.1016\/j.jid.2019.11.003","journal-title":"J Invest Dermatology"},{"key":"4567_CR70","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.clindermatol.2021.03.006","volume":"39","author":"R Abdlaty","year":"2021","unstructured":"Abdlaty R, Fang Q (2021) Skin erythema assessment techniques. Clin Dermatol 39:591\u2013604. https:\/\/doi.org\/10.1016\/j.clindermatol.2021.03.006","journal-title":"Clin Dermatol"},{"key":"4567_CR71","doi-asserted-by":"publisher","first-page":"14673","DOI":"10.1038\/s41598-024-63274-7","volume":"14","author":"Y-W Huang","year":"2024","unstructured":"Huang Y-W, Arkesteijn W, Lai Y-J, Ng CY (2024) A comparative study of an advanced skin imaging system in diagnosing facial pigmentary and inflammatory conditions. Sci Rep 14:14673. https:\/\/doi.org\/10.1038\/s41598-024-63274-7","journal-title":"Sci Rep"},{"key":"4567_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/srt.12109","volume":"20","author":"M Baqui\u00e9","year":"2014","unstructured":"Baqui\u00e9 M, Kasraee B (2014) Discrimination between cutaneous pigmentation and erythema: comparison of the skin colorimeters dermacatch and mexameter. Skin Res Technol 20:218\u2013227. https:\/\/doi.org\/10.1111\/srt.12109","journal-title":"Skin Res Technol"},{"key":"4567_CR73","doi-asserted-by":"publisher","first-page":"1276906","DOI":"10.3389\/fpsyt.2023.1276906","volume":"14","author":"W Chen","year":"2024","unstructured":"Chen W, Wan Y, Sun Y et al (2024) Prevalence of depression in melasma: a systematic review and meta-analysis. Front Psychiatry 14:1276906. https:\/\/doi.org\/10.3389\/fpsyt.2023.1276906","journal-title":"Front Psychiatry"},{"key":"4567_CR74","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2147\/CCID.S473224","volume":"17","author":"M Barbosa","year":"2024","unstructured":"Barbosa M, de Amorim R, Cassiano D et al (2024) Efficacy and safety of nicotinamide 10%, associated with magnesium ascorbyl phosphate 5% and hyaluronic acid 5%, compared to hydroquinone 4% in women with facial melasma: A randomized, Double-Blind, controlled clinical trial. Clin Cosmet Invest Dermatology Volume 17:2215\u20132223. https:\/\/doi.org\/10.2147\/CCID.S473224","journal-title":"Clin Cosmet Invest Dermatology Volume"},{"key":"4567_CR75","doi-asserted-by":"publisher","first-page":"e0262833","DOI":"10.1371\/journal.pone.0262833","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zeng X, Ying J et al (2022) Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. PLoS ONE 17:e0262833. https:\/\/doi.org\/10.1371\/journal.pone.0262833","journal-title":"PLoS ONE"},{"key":"4567_CR76","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jsps.2022.01.020","volume":"30","author":"FD Alosaimi","year":"2022","unstructured":"Alosaimi FD, Alsaleh FS, Alsughayer LY et al (2022) Psychosocial and clinical predictors of patient satisfaction with cancer care. Saudi Pharm J 30:414\u2013420. https:\/\/doi.org\/10.1016\/j.jsps.2022.01.020","journal-title":"Saudi Pharm J"},{"key":"4567_CR77","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1590\/abd1806-4841.20186780","volume":"93","author":"CF Pollo","year":"2018","unstructured":"Pollo CF, Miot LDB, Meneguin S, Miot HA (2018) Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma). An Bras Dermatol 93:391\u2013396. https:\/\/doi.org\/10.1590\/abd1806-4841.20186780","journal-title":"An Bras Dermatol"},{"key":"4567_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00403-025-03935-3","volume":"317","author":"LO Silva","year":"2025","unstructured":"Silva LO, Da Silva AJ, De Bona Sartor AT et al (2025) Photobiomodulation (100 mW) caution applied to tattooed skin: a cross-sectional study. Arch Dermatol Res 317:403. https:\/\/doi.org\/10.1007\/s00403-025-03935-3","journal-title":"Arch Dermatol Res"},{"key":"4567_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","volume":"64","author":"AG Pandya","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R et al (2011) Reliability assessment and validation of the melasma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64:78\u201383e2. https:\/\/doi.org\/10.1016\/j.jaad.2009.10.051","journal-title":"J Am Acad Dermatol"},{"key":"4567_CR80","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00403-022-02472-7","volume":"315","author":"C Kritsanaviparkporn","year":"2022","unstructured":"Kritsanaviparkporn C, Treesirichod A (2022) Comparing the efficacy and safety profiles of 0.025% and 0.05% tretinoin creams in treating acanthosis nigricans: a randomized double-blinded study. Arch Dermatol Res 315:963\u2013970. https:\/\/doi.org\/10.1007\/s00403-022-02472-7","journal-title":"Arch Dermatol Res"},{"key":"4567_CR81","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/ijd.17117","volume":"63","author":"S Guida","year":"2024","unstructured":"Guida S, Longo C, Ronga R et al (2024) Melasma and reflectance confocal microscopy: from baseline to treatment monitoring. Int J Dermatology 63:1007\u20131012. https:\/\/doi.org\/10.1111\/ijd.17117","journal-title":"Int J Dermatology"},{"key":"4567_CR82","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/lsm.23345","volume":"53","author":"H Pomerantz","year":"2021","unstructured":"Pomerantz H, Christman MP, Bloom BS et al (2021) Dynamic optical coherence tomography of cutaneous blood vessels in melasma and vessel response to oral Tranexamic acid. Lasers Surg Med 53:861\u2013864. https:\/\/doi.org\/10.1002\/lsm.23345","journal-title":"Lasers Surg Med"},{"key":"4567_CR83","doi-asserted-by":"publisher","unstructured":"Yang C-Y, Lin J-H, Chen C-M (2024) Optical coherence tomography as a Diagnosis-Assisted tool for guiding the treatment of melasma: A case series study. Diagnostics 14(2083). https:\/\/doi.org\/10.3390\/diagnostics14182083","DOI":"10.3390\/diagnostics14182083"},{"key":"4567_CR84","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002488","author":"J Wan","year":"2023","unstructured":"Wan J, Liao Z, Dong B et al (2023) Targeting senescent dermal fibroblasts responsible for hyperactive melanocytes in melasma. Chin Med J. https:\/\/doi.org\/10.1097\/CM9.0000000000002488","journal-title":"Chin Med J"},{"key":"4567_CR85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jocd.14110","volume":"21","author":"JN Mehrabi","year":"2022","unstructured":"Mehrabi JN, Bar-Ilan E, Wasim S et al (2022) A review of combined treatments for melasma involving energy\u2010based devices and proposed pathogenesis\u2010oriented combinations. J Cosmet Dermatol 21:461\u2013472. https:\/\/doi.org\/10.1111\/jocd.14110","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10103-023-03810-5","volume":"38","author":"QA Khan","year":"2023","unstructured":"Khan QA, Abdi P, Farkouh C et al (2023) Effectiveness of laser and topical Tranexamic acid combination therapy in melasma: an updated systematic review and meta-analysis of randomized controlled trials. Lasers Med Sci 38:139. https:\/\/doi.org\/10.1007\/s10103-023-03810-5","journal-title":"Lasers Med Sci"},{"key":"4567_CR87","doi-asserted-by":"publisher","unstructured":"Prasad N, Singh M, Malhotra S et al (2023) Comparative efficacy of chemical peeling agents in the treatment of melasma. https:\/\/doi.org\/10.7759\/cureus.47312. Cureus","DOI":"10.7759\/cureus.47312"},{"key":"4567_CR88","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1111\/jocd.16404","volume":"23","author":"K Shurrab","year":"2024","unstructured":"Shurrab K, Alzghayar JN (2024) Low-level laser therapy for skin rejuvenation: A safe and effective solution baked by data and visual evidence. J Cosmet Dermatol 23:3234\u20133240. https:\/\/doi.org\/10.1111\/jocd.16404","journal-title":"J Cosmet Dermatol"},{"key":"4567_CR89","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/photob.2022.0114","volume":"41","author":"LR Mota","year":"2023","unstructured":"Mota LR, Duarte IdaS, Galache TR, Photobiomodulation et al (2023) Photomed Laser Surg 41:48\u201356. https:\/\/doi.org\/10.1089\/photob.2022.0114","journal-title":"Photomed Laser Surg"},{"key":"4567_CR90","doi-asserted-by":"publisher","first-page":"e021419","DOI":"10.1136\/bmjopen-2017-021419","volume":"8","author":"L Rocha Mota","year":"2018","unstructured":"Rocha Mota L, Motta LJ, Duarte IDS et al (2018) Efficacy of phototherapy to treat facial ageing when using a red versus an amber LED: a protocol for a randomised controlled trial. BMJ Open 8:e021419. https:\/\/doi.org\/10.1136\/bmjopen-2017-021419","journal-title":"BMJ Open"},{"key":"4567_CR91","doi-asserted-by":"publisher","unstructured":"Olugbade I (2024) The use of Tranexamic acid and microneedling in the treatment of melasma: A systematic review. https:\/\/doi.org\/10.12788\/cutis.1080. Cutis 114:","DOI":"10.12788\/cutis.1080"},{"key":"4567_CR92","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1111\/jocd.15287","volume":"21","author":"J Brasil Dos Santos","year":"2022","unstructured":"Brasil Dos Santos J, Nagem Lopes LP, De Lima GG et al (2022) Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review. J Cosmet Dermatology 21:5680\u20135695. https:\/\/doi.org\/10.1111\/jocd.15287","journal-title":"J Cosmet Dermatology"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04567-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04567-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:25:46Z","timestamp":1771399546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04567-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4567"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04567-9","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Research Ethics Committee of the Universidade Nove de Julho (UNINOVE) 5,332,384.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants completed the patient informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors have no disclosures.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of conflicts of interest"}},{"value":"Clinical Trials No. NCT05326997.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}],"article-number":"313"}}